The study further demonstrated that the overexpression of ANRIL reduces p21 and KLF2 by inducing EZH2 and modulates proliferation in NSCLC while the knockdown of ANRIL regulates apoptosis and cell-cycle arrest by halting the NSCLC progression. The gene discussed is CDKN2B-AS1; the disease is non-small cell lung carcinoma.